Article
Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations.
American journal of clinical pathology - 1 Jun 2015
Mochel Mark C, Piris Adriano, Nose Vania, Hoang Mai P
Abstract excerpt
OBJECTIVES: Patients with heterozygous germline mutations in BRCA1-associated protein 1 (BAP1), a tumor suppressor gene, develop a tumor predisposition syndrome (OMIM 614327) with increased risk of uveal and cutaneous melanomas, cutaneous atypical and epithelioid melanocytic lesions, lung adenocarcinoma, clear cell renal cell carcinoma, and other tumors. Early recognition of this syndrome is of clinical...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
